Nuclear Medicine

Nuclear medicine (also called molecular imaging) includes positron emission computed tomography (PET) and single photon emission computed tomography (SPECT) imaging. Nuclear imaging is achieved by injecting small amounts of radioactive material (radiopharmaceuticals) into patients before or during their scan. These can use sugars or chemical traits to bond to specific cells. The radioactive material is taken up by cells that consume the sugars. The radiation emitted from inside the body is detected by photon detectors outside the body. Computers take the data to assemble images of the radiation emissions. Nuclear images may appear fuzzy or ghostly rather than the sharper resolution from MRI and CT.  But, it provides metabolic information at a cellular level, showing if there are defects in the function of the heart, areas of very high metabolic activity associated with cancer cells, or areas of inflammation, data not available from other modalities. These noninvasive imaging exams are used to diagnose cancer, heart disease, Alzheimer’s and Parkinson’s disease, bone disorders and other disorders. 

RSS icon
Thumbnail

Machine learning combined with PET/CT can predict heart attack risk

“We showed that risk prediction does not depend on cardiovascular risk scores, stenosis severity or CT calcium scoring," researchers said in the Journal of Nuclear Medicine.

Thumbnail

RSNA partners with RadSite on FDG-PET/CT biomarker pilot program

The effort is focused on outpatient imaging centers and should bring more consistency to cancer treatment and therapy.

quality

Nuclear medicine leader says patient-first imaging providers must keep close eye on quality

That includes utilizing the most up-to-date protocols and equipment, among many other things, ASNC President Randall C. Thompson said.

Thumbnail

Physicians support use of PET/CT scans in pregnant women with cancer, survey finds

Researchers say scans pose little risk to an unborn fetus but maintained doctors must weigh the benefits against potential risks.

Thumbnail

Top medical groups release new appropriate use criteria for PSMA-PET imaging

SNMMI is among the many organizations that collaborated on the updated guidance for imaging prostate cancer.

District of Columbia DC congress capitol hill

Lawmakers request records from FDA on Alzheimer’s drug approval, citing ‘apparent anomalies’

Part of their list includes info regarding the agency's move to approve Aduhelm for broader treatment indications than studied during clinical testing, a gripe similar to complaints cited by SNMMI.

Thumbnail

Transformative prostate cancer therapy ‘should not be accepted’ without PET imaging

Two Stanford University experts made their case for using molecular imaging to select patients for 177-Lu-PSMA-617 in a new Journal of Nuclear Medicine editorial.

Thumbnail

As regulators weigh revising nuclear medicine reporting rules, imaging advocates and others take sides

Researchers say extravasations should be more closely monitored and reported, while the ACR and SNMMI caution these events are rare and don't require intense scrutiny.

Displaying 201 - 208 of 245

Around the web

Cardiovascular Business
GE HealthCare launches new cardiac CT scanner with advanced AI capabilities

GE HealthCare designed the new-look Revolution Vibe CT scanner to help hospitals and health systems embrace CCTA and improve overall efficiency.

Cardiovascular Business
Bracco updates HeartSee coronary flow capacity software with new diagnostic features

Clinicians have been using HeartSee to diagnose and treat coronary artery disease since the technology first debuted back in 2018. These latest updates, set to roll out to existing users, are designed to improve diagnostic performance and user access.

Cardiovascular Business
Key trends in diagnostic heart testing: CT on the rise as some traditional techniques fall out of favor

The cardiac technologies clinicians use for CVD evaluations have changed significantly in recent years, according to a new analysis of CMS data. While some modalities are on the rise, others are being utilized much less than ever before.